KPIs & Operating Metrics(New)
Cash Flow Statement
Growth Metrics

Bausch Health Companies (BHC) EPS (Weighted Average and Diluted) (2016 - 2026)

Bausch Health Companies' EPS (Weighted Average and Diluted) history spans 18 years, with the latest figure at -$3.82 for Q1 2026.

  • On a quarterly basis, EPS (Weighted Average and Diluted) fell 2287.5% to -$3.82 in Q1 2026 year-over-year; TTM through Mar 2026 was -$3.24, a 2845.45% decrease, with the full-year FY2025 number at $0.42, up 423.08% from a year prior.
  • EPS (Weighted Average and Diluted) hit -$3.82 in Q1 2026 for Bausch Health Companies, down from -$0.3 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for BHC hit a ceiling of $1.1 in Q3 2022 and a floor of -$3.82 in Q1 2026.
  • Historically, EPS (Weighted Average and Diluted) has averaged -$0.34 across 5 years, with a median of -$0.17 in 2024.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): surged 1233.33% in 2025 and later plummeted 2287.5% in 2026.
  • Tracing BHC's EPS (Weighted Average and Diluted) over 5 years: stood at -$1.13 in 2022, then soared by 91.15% to -$0.1 in 2023, then skyrocketed by 350.0% to $0.25 in 2024, then crashed by 220.0% to -$0.3 in 2025, then crashed by 1173.33% to -$3.82 in 2026.
  • Business Quant data shows EPS (Weighted Average and Diluted) for BHC at -$3.82 in Q1 2026, -$0.3 in Q4 2025, and $0.48 in Q3 2025.